Key Findings
The France blood flow measurement devices market is anticipated to develop with a CAGR of 8.95% over the forecasting period. The country’s market growth is propelled by key factors, including the increasing focus on research and development, the rising healthcare expenditure, and the growing incidence of chronic conditions. While the base year considered for the market studied is 2020, the forecasting years are from 2021 to 2026.

Market Insights
As per the estimates issued by the government of France, for 2017, while 13% of medical device manufacturers were completely focused on research, 20% engaged in commercial endeavors, and 60% facilitated manufacturing operations. Furthermore, the French medical device sector houses more than 1,340 companies, generating revenues worth ?28 billion. As a result, these aspects make France a significant market for blood flow monitoring devices.
Conversely, up to 12% of the general population in France suffers from peripheral arterial disease (PAD), and the condition reaches nearly 20% in individuals older than 70 years old. This percentage is significantly higher in patients with cardiovascular risk factors such as diabetes, smoking, and hypertension, among others. In addition, drivers like the surging prevalence of chronic disorders, the growing demand for sophisticated healthcare infrastructure associated with technologically advanced products, as well as the increasing elderly populace have augmented the demand for blood flow measurement devices. Therefore, the aforementioned factors are expected to reinforce the market growth in France during the forecast years.

Regional Insights
Some of the key companies operating in the market are GE Healthcare, Siemens Healthineers, Medtronic PLC, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments